Trial Profile
Darexaban maleate pharmacokinetics in female and male volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 12 Mar 2011
Price :
$35
*
At a glance
- Drugs Darexaban (Primary)
- Indications Acute coronary syndromes; Thromboembolism; Venous thromboembolism
- Focus Pharmacokinetics
- Sponsors Astellas Pharma Europe Ltd
- 12 Mar 2011 New trial record